Abstract
The toxicity of fourteen widely used human pharmaceuticals was determined using the Frog Embryo Teratogenesis Assay–Xenopus (FETAX). Stage 9 Xenopus blastulae were exposed for 96 h to single concentrations of commonly prescribed selective serotonin reuptake inhibitors (SSRIs), statin blood lipid regulators, non-steroidal anti-inflammatories, antibiotics, a stimulant, and an anti-epileptic. Toxicity, teratogenicity, minimum concentration to inhibit growth, and types and severity of associated malformations were determined. EC10s ranged from 3.0 mg/l to >100 mg/l and LC10s ranged from 3.6 mg/l to >100 mg/l. Toxicity varied between and within compound class of pharmaceutical. The fluoroquinolones, stimulants, anti-epileptics, and antibiotics tested were determined to be nontoxic and non-teratogenic at singular, water-soluble concentrations. The hazard quotients (HQ) for the pharmaceuticals ranged from 6.10 × 10−7 to 1.6 × 10−4, all of which are orders of magnitude below EPA’s levels for concern for harm to aquatic animals. Thus, based on the data from the present study, concentrations of individual pharmaceuticals currently detected in surface water are far below concentrations of effective and lethal concentrations.
Similar content being viewed by others
References
Arkhipova OV, Grishin SN, Sitdikova GF, Zefirov AL (2005) Presynaptic effects of arachidonic acid and prostaglandin E2 in the frog neuromuscular synapse. Ross Fiziol Zh Im I M Sechenova 91:268–276
Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333:167–184
ASTM (2002) Standard guide for conducting the frog embryo teratogenesis assay—Xenopus (FETAX). In: Annual book of ASTM standards, water and environmental technology. PE, ASTM, Philadelphia, PA, pp E1439–E1498
Boyd GR, Reemtsma H, Grimm DA, Mitra S (2003) Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ 311:135–149
Cahill JD, Furlong ET, Burkhardt MR, Kolpin D, Anderson LG (2004) Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromotogr A 1041:171–180
Chambers HF (2001) Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Hardman JG, Limbird LE (eds), Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, NY, pp 1239–1271
Chen F, Lo HJ (2003) Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect 36:1–9
Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:907–938
ECETOC (2001) Aquatic toxicity of mixtures. Brussels, Belgium: European Centre for Ecotoxicology and Toxicology of Chemicals. Report nr Technical Report No. 80. 64 p
Els WJ, Helman SI (1997) Dual role of prostaglandins (PGE2) in regulation of channel density and open probability of epithelial Na+ channels in frog skin (R. pipiens). J Membr Biol 155:75–87
Fabro S, Shull G, Brown NA (1982) The relative teratogenic index and teratogenic potency: proposed components of developmental toxicity risk assessment. Teratog Carcinog Mutag 2:61–76
Farre ML, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M, Barcelo D (2001) Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio Fischeri. J Chromatogr A 938:187–197
Fong PP, Philbert CM, Roberts BJ (2003) Putative seratonin reuptake inhibitor-induced spawning and parturition in freshwater bivalves is inhibited by mammalian 5-HT2 receptor antagonists. J Exp Zoolog A Comp Exp Bio 298:67–72
Fort DJ, James BL, Bantle JA (1989) Evaluation of the developmental toxicity of 5 compounds with the frog embryo teratogenesis assay – Xenopus (Fetax) and a metabolic-activation system. J Appl Toxicol 9(6):377–388
Fort DJ, Stover EL, Propst TL, Faulkner BC, Vollmuth TA, Murray FJ (1998) Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay—Xenopus (FETAX). Food Chem Toxicol 36:591–600
Fraker SL, Smith GR (2004) Direct and interactive effects of ecologically relevant concentrations of organic wastewater contaminants on Rana pipiens tadpoles. Environ Toxicol 19(3):250–256
Fraker SL, Smith GR (2005) Effects of two organic wastewater contaminants on Xenopus laevis tadpoles. Appl Herpetol 2:381–388
Goodnick PJ, Goldstein BJ (1998) Selective serotonin reuptake inhibitors in affective disorders—I. Basic pharmacology. J Psychopharmacol 12:S5–S20
Heberer T (2002) Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 266:175–189
Hirsch R, Ternes T, Haberer K, Kratz KL (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109–118
van der Hoeven N, Noppert F, Leopold A (1997b). How to measure no effect? Part I. Towards a new measure of chronic toxicity in ecotoxicology, introduction and workshop results. Environmetrics 8:241–248
van der Hoeven N (1997a) How to measure no effect? Part III. Statistical aspects of NOEC, ECx and NEC estimates. Environmetrics 8:255–261
Huber R, Smith K, Delago A, Isaksson K, Kravitz EA (1997) Serotonin and aggressive motivation in crustaceans: altering the decision to retreat. Proc Natl Acad Sci 94:5939–95942
Johnson DJ, Sanderson H, Brain RA, Wilson CJ, Bestari KJ, Solomon KR (2005) Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors. Regul Toxicol Pharmacol 42:313–323
Jones-Lepp, TL Alvarez DA, Petty JD, Osemwengie LI, Daughton CG (2001) Analytical chemistry research needs for mapping trends of pharmaceutical and personal care product pollution from personal use: some current research and future needs. Presented at The 10th Symposium on Handling of Environmental and Biological Samples in Chromatography. 1–4 April, 2001, Mainz/Wiesbaden, Germany
von Keutz E, Schluter G (1998) Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor. Am J Cardiol 4B:11J–17J
Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211
Lam MW, Mabury SA (2005) Photodegradation of the pharmaceuticals atorvastatin, carbamazepine, levofloxacin, and sulfamethoxazole in natural waters. Aq Sci 67:177–188
Lien NTH, Adriaens D, Janssen CR (1997) Morphological abnormalities in African catfish (Clarias garieupinus) larvae exposed to malathion. Chemosphere 35:1475–1486
Lin JH, Lu AYH (1998) Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35:361–390
McLean MJ, Macdonald RL (1986) Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 238:727–738
McNamara JO (2001) Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE (eds), Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, NY, pp 521–547
Metcalfe CD, Miao XS (2003a) Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometry. J Mass Spectrom 38:27–34
Metcalfe CD, Miao XS, Koenig BG, Struger J (2003b) Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes. Canada Environ Toxicol Chem 22:2881–2889
Minsker DH, MacDonald JS, Robertson RT, Bokelman DL (1983) Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Teratology 28:449–456
Moore KL, Persaud TVN (2003) The developing human: clinically oriented embryology, 7th edn. WB Saunders Company, Philadelphia, PA
Morrow JD, Roberts LJ (2001) Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Hardman JG, Limbird LE (eds), Goodman and Gilman’s The pharmacological basis of therapeutics. McGraw-Hill, New York, NY, pp 669–686
NDC Health (2005) The top 200 prescriptions: 2004 US prescriptions based on more than 2.4 billion U.S. prescriptions. RxList: The Internet Drug Index. Available online: www.rxlist.com/top200.htm. Access date: July 19th, 2005
Newman MC (1995) Quantitative methods in aquatic ecotoxicology. Lewis Publishers, Boca Raton, FL
Nieuwkoop PD, Faber J (1994) Normal table of Xenopus laevis (Daudin): a systematical and chronological survey of the development from the fertilized egg till the end of metamorphosis. Garland Publishing, Inc, New York, NY
O’Brien CP (2001) Drug addiction and drug abuse. In: Hardman JG, Limbird LE (eds), Goodman and Gilman’s The pharmacological basis of therapeutics. McGraw-Hill, New York, NY
Petri WA (2001) Sulfonamides, trimethoprim-sulfamethoxazol, quinolones, and agents for urinary tract infections. In: Hardman JG, Limbird LE (eds), Goodman and Gilman’s The pharmacological basis of therapeutics. McGraw-Hill, New York, NY, pp 1171–1188
Pickrell J (2002) Killer cocktails: drug mixes threaten aquatic ecosystems. Science News 162:101
Richards SM, Kendall RJ (2002) Biochemical effects of chlorpyrifos on two stages of Xenopus laevis. Environ Toxicol Chem 21:1826–1835
Richards SM, Kendall RJ (2003) Physical effects of chlorpyrifos on two stages of Xenopus laevis. J Toxicol Environ Health A 66:75–91
Sakamoto MK, Mima S, Kihara T, Matsuo T, Yasuda Y, Tanimura T (1993) Developmental toxicity of caffeine in the larvae of Xenopus-Laevis. Teratol 47(3):189–201
Schloss PW, Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115–121
Schooley RT, Wagley PF, Lietman PS (1977) Edema associated with ibuprofen therapy. JAMA 237:1716–1717
Shuey DL, Sadler TW, Lauder JM (1992) Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology 46:367–378
Smith GR, Burgett AA (2005) Effects of three organic wastewater contaminants on American toad, Bufo americanus, tadpoles. Ecotoxicology 14(4):477– 482
Stumpf M, Ternes TA, Wilken RD, Rodrigues SV, Baumann W (1999) Polar drug residues in sewage and natural waters in the state of Rio de Janiero, Brazil. Sci Total Environ 225:135–141
Teraoka H, Urakawa S, Nanba S, Nagai Y, Dong W, Imagawa T, Tanguay RL, Svoboda K, Handley-Goldstone HM, Stegeman JJ, Hiraga T (2006) Muscular contractions in the zebrafish embryo are necessary to reveal thiuram-induced notochord distortions. Toxicol Appl Pharmacol 212:24–34
Thomas KV, Hilton MJ (2004) The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar Pollut Bull 49:436–444
USEPA (1988) EPA Probit analysis program for calculating EC/LC values. Version 1.5. United States Environmental Protection Agency, Cincinnati, OH
USEPA (1998) Guidelines for ecological risk assessment. risk assessment forum, EPA/630/R095/002F. United States Environmental Protection Agency, Washington, DC
Wang H (1987) Factors affecting metal toxicity to (and bioaccumulation by) aquatic organisms—overview. Environ Int 13:437–457
Zubay G (1999) Biochemistry, 4th edn. Wm. C. Brown Publishers, Dubuque, IA
Zuehlke S, Duennbier U, Heberer T (2004) Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry. Anal Chem 76(22):6548–6554
Acknowledgments
This research was supported by a UC Foundation Research Grant (University of Tennessee at Chattanooga). The authors thank Dr. Mark Hanson for his thorough review and input.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Richards, S.M., Cole, S.E. A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology 15, 647–656 (2006). https://doi.org/10.1007/s10646-006-0102-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10646-006-0102-4